(L-R) Dr. Eytan Mor with one of his liver transplant recipients, Mr Amzaleg Hanania
The director of the Department of Organ Transplantation at Rabin Medical Center, Professor Eytan Mor, recently visited New York City and spoke to American Friends of Rabin Medical Center supporters of the pioneering work in organ transplantation.
Rabin Medical Center conducts the majority - over 60 percent - of organ transplants in Israel. The statistics are impressive. From 1982-2004, Rabin Medical Center conducted:
Rabin Medical Center is the first hospital in Israel to achieve a crossover kidney transplant where two partners exchange kidneys because their own donor was not a compatible blood type. Doctors also completed the first living-relative liver transplants - parent to child and adult to adult; the first successful split liver transplant operation - a liver is split into two parts and is shared between a child and an adult; and the first domino transplant - a block of heart-lung is transplanted in one patient and the removed heart is transplanted in another patient.
Prof. Mor pointed to new frontiers in embryonic tissue transplants and transformed hepatocytes to islet cells. New embryonic tissues are grown in animals and then transplanted into humans with the hope of self-regeneration. Also, great strides are occuring in immune suppression and drug protocols.
The long-range goals of Rabin Medical Center are to increase the number of liver transplants, and to improve pre-transplant patient screening and post-transplantation drug protocols.
It was perhaps ironic that on the day that a special emergency exercise in the event of a chemical attack in a central neighborhood was held at Rabin Medical Center a real rocket fell in Beer Sheva showing the importance of always being prepared.
A group of researchers from Tel Aviv University has discovered how malignant tumors from melanoma, the deadly skin cancer, work. The group is led by a young lecturer and researcher, Dr. Carmit Levy.
Volunteer delegation of Israeli medical professionals travel to Kyrgyzstan to treat patients, many of them blind for many years • "Many remain blind only because the doctors in their country don't have the means to treat them," says delegation director.